IndraLab

Statements


Hydroxychloroquine inhibits fusion. 2 / 2
| 2

eidos
"Hydroxychloroquine , an anti-malarial drug , facilitates endosomal acidification and blocks viral entry and fusion by inhibiting glycosylation of the host cellular receptors that bind with the viral proteins ( Sanders et al ., 2020 ) ."

eidos
"The synergistic effect can be produced by using both drugs as Hydroxychloroquine inhibits viral entry & fusion while Nitazoxanide up regulates innate immune response to prevent on-going viral replication ."